Top compounds associated with response to MYO1C


Feature Type Standardized
Nominal ANOVA
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.22 4e-08
mRNA PHA-793887 GDSC1000 pan-cancer AAC -0.2 5e-08
mRNA I-BET-762 GDSC1000 pan-cancer AAC -0.18 2e-07
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.22 2e-07
mRNA CX-5461 GDSC1000 pan-cancer AAC -0.21 4e-07
mRNA TL-2-105 GDSC1000 pan-cancer AAC -0.21 4e-07
mRNA IOX2 GDSC1000 pan-cancer AAC 0.21 6e-07
mRNA CHIR-99021 GDSC1000 pan-cancer AAC 0.19 2e-06
mRNA CAY10603 GDSC1000 pan-cancer AAC -0.18 2e-06
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.19 2e-06
Download CSV